These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15628831)

  • 21. Fat redistribution and bone abnormalities in HIV-infected patients.
    Tebas P
    J Int Assoc Physicians AIDS Care (Chic); 2003; 2(2):59-65. PubMed ID: 12961759
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
    Casals-Seoane F; Chaparro M; Maté J; Gisbert JP
    Inflamm Bowel Dis; 2016 Aug; 22(8):1929-36. PubMed ID: 27135482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
    Cotter AG; Powderly WG
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):501-15. PubMed ID: 21663843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV and bone health.
    Sharp M
    BETA; 2011; 23(2):28-37. PubMed ID: 22567820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone disease and HIV infection.
    Amorosa V; Tebas P
    Clin Infect Dis; 2006 Jan; 42(1):108-14. PubMed ID: 16323100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic.
    Pinzone MR; Di Rosa M; Malaguarnera M; Madeddu G; Focà E; Ceccarelli G; d'Ettorre G; Vullo V; Fisichella R; Cacopardo B; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1218-32. PubMed ID: 23690192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
    Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous supracondylar femoral fracture in an HIV patient in lotus position.
    Pinto Neto LF; Eis SR; Miranda AE
    J Clin Densitom; 2011; 14(1):74-6. PubMed ID: 21295744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone disorders, hypertension, and mitochondrial toxicity in HIV disease.
    Newman MD
    Top HIV Med; 2003; 11(1):10-5. PubMed ID: 12717045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis.
    Guaraldi G; Orlando G; Madeddu G; Vescini F; Ventura P; Campostrini S; Mura MS; Parise N; Caudarella R; Esposito R
    HIV Clin Trials; 2004; 5(5):269-77. PubMed ID: 15562367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.
    Bruera D; Luna N; David DO; Bergoglio LM; Zamudio J
    AIDS; 2003 Sep; 17(13):1917-23. PubMed ID: 12960824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV and bone disease.
    Stone B; Dockrell D; Bowman C; McCloskey E
    Arch Biochem Biophys; 2010 Nov; 503(1):66-77. PubMed ID: 20682280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
    Pinzone MR; Moreno S; Cacopardo B; Nunnari G
    AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
    Brim NM; Cu-Uvin S; Hu SL; O'Bell JW
    AIDS Read; 2007 Jun; 17(6):322-8, C3. PubMed ID: 17632940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of bone mineral density in HIV-infected patients.
    Negredo E; Bonjoch A; Clotet B
    Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
    Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
    J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for the treatment of decreased bone mineral density associated with HIV infection.
    Lin D; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005645. PubMed ID: 17443607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporotic fractures: background and prevention strategies.
    Wark JD
    Maturitas; 1996 Mar; 23(2):193-207. PubMed ID: 8735357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.